Charles E Massie

Summary

Affiliation: University of Cambridge
Country: UK

Publications

  1. doi request reprint Global identification of androgen response elements
    Charles E Massie
    Cancer Research UK, Cambridge Research Institute, Cambridge, UK
    Methods Mol Biol 776:255-73. 2011
  2. doi request reprint Mapping protein-DNA interactions using ChIP-sequencing
    Charles E Massie
    CRUK Cambridge Research Institute, Department of Haematology, Cambridge, UK
    Methods Mol Biol 809:157-73. 2012
  3. pmc HES5 silencing is an early and recurrent change in prostate tumourigenesis
    Charles E Massie
    Cancer Research UK Cambridge InstituteUniversity of Cambridge, Cambridge, CB2 0RE, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, Sutton, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, Norwich, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke s Hospital, Hills Road, Cambridge, UK
    Endocr Relat Cancer 22:131-44. 2015
  4. doi request reprint Chromatin immunoprecipitation (ChIP) methodology and readouts
    Charles E Massie
    Uro Oncology Research Group, Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
    Methods Mol Biol 505:123-37. 2009
  5. pmc The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
    Charles E Massie
    CRUK Cambridge Research Institute, Cambridge, UK
    EMBO J 30:2719-33. 2011

Detail Information

Publications5

  1. doi request reprint Global identification of androgen response elements
    Charles E Massie
    Cancer Research UK, Cambridge Research Institute, Cambridge, UK
    Methods Mol Biol 776:255-73. 2011
    ....
  2. doi request reprint Mapping protein-DNA interactions using ChIP-sequencing
    Charles E Massie
    CRUK Cambridge Research Institute, Department of Haematology, Cambridge, UK
    Methods Mol Biol 809:157-73. 2012
    ..Herein, we provide a comparison of high-throughput sequencing platforms and a survey of ChIP-seq analysis tools, discuss experimental design, and describe a detailed ChIP-seq method...
  3. pmc HES5 silencing is an early and recurrent change in prostate tumourigenesis
    Charles E Massie
    Cancer Research UK Cambridge InstituteUniversity of Cambridge, Cambridge, CB2 0RE, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, Sutton, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, Norwich, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke s Hospital, Hills Road, Cambridge, UK
    Endocr Relat Cancer 22:131-44. 2015
    ..Finally, we identify and test a transcriptional module involving the AR, ERG, HES1 and HES6 and propose a model for the impact of HES5 silencing on tumourigenesis as a starting point for future functional studies. ..
  4. doi request reprint Chromatin immunoprecipitation (ChIP) methodology and readouts
    Charles E Massie
    Uro Oncology Research Group, Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
    Methods Mol Biol 505:123-37. 2009
    ..The application of ChIP-based approaches has redefined consensus binding motifs for transcription factors and provided important insights into transcription factor biology...
  5. pmc The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
    Charles E Massie
    CRUK Cambridge Research Institute, Cambridge, UK
    EMBO J 30:2719-33. 2011
    ..In conclusion, it is possible to progress from transcriptional studies to a promising therapeutic target by taking an unbiased interdisciplinary approach...